Rowland Thomas Andrew

Track

Insider profile

Performance

Overall performance
1.0
Performance over holding periods
1.0
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Rowland Thomas Andrew's trades of ANI Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-13 2026-05-12
S Sale
85,447 -23.5%
75.74
US$1,712,960 		85,447 -23.5% 75.74 US$1,712,960
2026-03-13 2026-03-11
S Sale
12,910 +42.7%
404.17
US$413,446 		12,910 +42.7% 404.17 US$413,446
2025-08-14 2025-08-12
PlS Planned sale
4,326 +36.2%
40.80
US$501,478 		4,326 +36.2% 40.80 US$501,478